This presentation outlines the importance of long-term follow-up care after a bone marrow/stem cell transplant using donor cells (allogeneic transplant) focused on supportive care for side effects post-transplant, identifying new health issues early, and providing resources and guidance to ensure the patient is experiencing their optimal quality of life after treatment.

This presentation discusses what a clinical trial is, why they are necessary, the phases of a clinical research trials, how they are reviewed to ensure patient safety, the process involved in participating in a clinical trial, and where one can go to receive further information about clinical trials. 

Bone marrow/stem cell transplant survivors need a comprehensive plan for long-term follow-up care. This presentation discusses the challenges survivors face in accessing this care and strategies to overcome these challenges.

Las personas que se someten a un trasplante de médula ósea/células madre utilizando células de un donante (trasplante alogénico) generalmente se curan, pero pueden tener efectos secundarios persistentes o que aparecen tardíamente.

El trasplante con células de un donante (trasplante alogénico) puede causar efectos tardíos en la salud meses o años después del trasplante. Este video describe posibles complicaciones tardías o a largo plazo después del trasplante, cómo reducir el riesgo de desarrollar complicaciones y opciones de tratamiento.

Los pacientes que se someten a un alotrasplante de células madre (un trasplante que utiliza células madre de un donante) tienen un mayor riesgo de sufrir problemas médicos adicionales a largo plazo. Aprenda cómo detectar y prevenir complicaciones tardías y a largo plazo después del trasplante.

The number of stem cell transplants performed is increasing, which means more people are concerned about ongoing complications or late effects after transplant. This presentation reviews potential late effects after a stem cell transplant (hematopoietic cell transplant) using donor cells (aka allogeneic transplant).

Great strides have been made in bone marrow, stem cell and cord blood transplantation. An increasing number of patients with blood disorders are now able to enjoy a second chance at life, thanks the efforts of doctors and patients who pioneered this life-saving treatment.